Read More

Bristol Myers’ Antitrust Allegations: Lawsuit Over Alleged Patent Deception For Blood Cancer Drug

Bristol Myers Squibb Co (NYSE: BMY) faces fresh allegations in a recent lawsuit, accused of employing deceptive patents and illicit strategies to preserve its dominant position in the blood cancer drug market with Pomalyst (pomalidomide) long after it should have faced competition from generic alternative

BMY

Read More

How To Earn $500 From Pfizer Stock With Shares Trading At 52-Week Low

President Joe Biden’s Inflation Reduction Act, which allows Medicare to negotiate the price of some prescription drugs, remains the talk of the town as investors sell off shares in pharmaceutical companies such as Pfizer Inc. (NYSE: PFE) because drugs associated with the compan

BMY